They also demonstrated that overexpression of these fused gene products led to enhanced proliferation in a benign breast cell line and that RNAi-mediated knockdown of MAST2 in a cancer cell line with MAST2 gene fusions led to reduced growth and reduced tumor formation in mice xenografts. This evidence concerns the gene MAST2 and neoplasm.